Non-competitive NMDA receptor antagonists are known to induce psychosis-like symptoms in rodents. Administration of such compounds cause behavioural effects such as memory impairment and hyperlocomotion. Additionally, drugs such as phencyclidine (PCP), ketamine and MK-801 all cause distinctive increases in striatal local field potential (LFP) in the high frequency oscillation (HFO) band in the power spectrum (140–180 Hz). Amperometric sensors provide a means to measure tissue oxygen (tO2; a BOLD-like signal) in the brains of freely-moving rats while simultaneously acquiring LFP using the same electrode. Carbon paste electrodes were implanted into the striatum and hippocampus of male Wistar rats. Rats were administered with saline, ketamine ...
International audienceIn prodromal and early schizophrenia, disorders of attention and perception ar...
International audienceIn prodromal and early schizophrenia, disorders of attention and perception ar...
Alterations in the function of the medial prefrontal cortex (mPFC) and its major thalamic source of ...
Non-competitive NMDA receptor antagonists are known to induce psychosis-like symptoms in rodents. Ad...
Non-competitive NMDA receptor antagonists are known to induce psychosis-like symptoms in rodents. Ad...
Non-competitive NMDA receptor antagonists are known to induce psychosis-like symptoms in rodents. Ad...
Background: The psychotomimetics ketamine and MK-801, non-competitive NMDA receptor (NMDAr) antagoni...
The psychotomimetics ketamine and MK-801, non-competitive NMDA receptor (NMDAr) antagonists, induce ...
Acute administration of NMDA receptor antagonists such as PCP and ketamine are accepted models of sc...
Non-competitive N-methyl-D-aspartate receptor antagonists mimic schizophrenia symptoms and produce i...
Introduction Ketamine and phencyclidine (PCP) act as noncompetitive antagonists to the N-methyl-D-as...
Antagonists of N-methyl-D-aspartate receptors (NMDAR) have psychotomimetic effects in humans and are...
<div><p>Antagonists of N-methyl-D-aspartate receptors (NMDAR) have psychotomimetic effects in humans...
Antagonists of N-methyl-D-aspartate receptors (NMDAR) have psychotomimetic effects in humans and are...
International audienceIn prodromal and early schizophrenia, disorders of attention and perception ar...
International audienceIn prodromal and early schizophrenia, disorders of attention and perception ar...
International audienceIn prodromal and early schizophrenia, disorders of attention and perception ar...
Alterations in the function of the medial prefrontal cortex (mPFC) and its major thalamic source of ...
Non-competitive NMDA receptor antagonists are known to induce psychosis-like symptoms in rodents. Ad...
Non-competitive NMDA receptor antagonists are known to induce psychosis-like symptoms in rodents. Ad...
Non-competitive NMDA receptor antagonists are known to induce psychosis-like symptoms in rodents. Ad...
Background: The psychotomimetics ketamine and MK-801, non-competitive NMDA receptor (NMDAr) antagoni...
The psychotomimetics ketamine and MK-801, non-competitive NMDA receptor (NMDAr) antagonists, induce ...
Acute administration of NMDA receptor antagonists such as PCP and ketamine are accepted models of sc...
Non-competitive N-methyl-D-aspartate receptor antagonists mimic schizophrenia symptoms and produce i...
Introduction Ketamine and phencyclidine (PCP) act as noncompetitive antagonists to the N-methyl-D-as...
Antagonists of N-methyl-D-aspartate receptors (NMDAR) have psychotomimetic effects in humans and are...
<div><p>Antagonists of N-methyl-D-aspartate receptors (NMDAR) have psychotomimetic effects in humans...
Antagonists of N-methyl-D-aspartate receptors (NMDAR) have psychotomimetic effects in humans and are...
International audienceIn prodromal and early schizophrenia, disorders of attention and perception ar...
International audienceIn prodromal and early schizophrenia, disorders of attention and perception ar...
International audienceIn prodromal and early schizophrenia, disorders of attention and perception ar...
Alterations in the function of the medial prefrontal cortex (mPFC) and its major thalamic source of ...